Fitting a Semi-Parametric Mixture Model for Competing Risks in Survival Data
From MaRDI portal
Publication:5450553
DOI10.1080/03610920701649134zbMath1139.62052MaRDI QIDQ5450553
Gabriel Escarela, Russell J. Bowater
Publication date: 12 March 2008
Published in: Communications in Statistics - Theory and Methods (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1080/03610920701649134
EM algorithm; product-limit estimate; event-specific hazard; multiple decrement data; split-population models
62P10: Applications of statistics to biology and medical sciences; meta analysis
62G05: Nonparametric estimation
62N01: Censored data models
62N02: Estimation in survival analysis and censored data
Related Items
Applying competing risks regression models: an overview, Modeling competing risks with a semi-parametric mixture model, Analysis of a semiparametric mixture model for competing risks
Cites Work
- Unnamed Item
- Unnamed Item
- Unnamed Item
- Unnamed Item
- Unnamed Item
- Cox's regression model for counting processes: A large sample study
- Asymptotic equivalence between the Cox estimator and the general ML estimators of regression and survival parameters in the Cox model
- Data. A collection of problems from many fields for the student and research worker
- Asymptotic score-statistic processes and tests for constant hazard against a change-point alternative
- An Extension of Cox's Regression Model
- Competing risk analyses with special reference to matched pair experiments
- A SEMIPARAMETRIC MIXTURE MODEL FOR THE ANALYSIS OF COMPETING RISKS DATA
- The Efficiency of Cox's Likelihood Function for Censored Data
- Semi-Markov models for partially censored data
- Regression Analysis of Grouped Survival Data with Application to Breast Cancer Data
- A Regression Survival Model for Testing the Proportional Hazards Hypothesis
- Prediction of Cumulative Incidence Function under the Proportional Hazards Model
- Marginal likelihoods based on Cox's regression and life model
- On the Use of Cause-Specific Failure and Conditional Failure Probabilities: Examples From Clinical Oncology Data
